- Home
- REPX vs CRON Comparison
REPX vs CRON Comparison
Compare REPX & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPX
- CRON
- Stock Information
- Founded
- REPX 2016
- CRON N/A
- Country
- REPX United States
- CRON Canada
- Employees
- REPX N/A
- CRON N/A
- Industry
- REPX Oil & Gas Production
- CRON Medicinal Chemicals and Botanical Products
- Sector
- REPX Energy
- CRON Health Care
- Exchange
- REPX Nasdaq
- CRON Nasdaq
- Market Cap
- REPX 574.1M
- CRON 684.7M
- IPO Year
- REPX N/A
- CRON N/A
- Fundamental
- Price
- REPX $27.88
- CRON $1.86
- Analyst Decision
- REPX Strong Buy
- CRON
- Analyst Count
- REPX 1
- CRON 0
- Target Price
- REPX $47.00
- CRON N/A
- AVG Volume (30 Days)
- REPX 98.8K
- CRON 1.6M
- Earning Date
- REPX 08-06-2025
- CRON 08-07-2025
- Dividend Yield
- REPX 5.42%
- CRON N/A
- EPS Growth
- REPX N/A
- CRON N/A
- EPS
- REPX 4.67
- CRON 0.13
- Revenue
- REPX $412,894,000.00
- CRON $124,589,000.00
- Revenue This Year
- REPX $2.85
- CRON $25.49
- Revenue Next Year
- REPX $4.05
- CRON $7.45
- P/E Ratio
- REPX $6.00
- CRON $14.59
- Revenue Growth
- REPX 1.25
- CRON 33.92
- 52 Week Low
- REPX $21.98
- CRON $1.60
- 52 Week High
- REPX $37.55
- CRON $2.54
- Technical
- Relative Strength Index (RSI)
- REPX 55.00
- CRON 38.80
- Support Level
- REPX $27.67
- CRON $1.92
- Resistance Level
- REPX $28.94
- CRON $2.01
- Average True Range (ATR)
- REPX 0.99
- CRON 0.05
- MACD
- REPX 0.09
- CRON -0.01
- Stochastic Oscillator
- REPX 63.64
- CRON 0.00
About REPX Riley Exploration Permian Inc.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties and Tennessee Properties, among others.
About CRON Cronos Group Inc. Common Share
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.